Do you want to read an article? Please log in or register.
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases
Lung, Respiratory and Thoracic Cancer